Virtual Medicinal Product (VMP) - Generic Minalka tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Generic Minalka tablets Start Date 04-07-2003 End Date

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Never Valid To Prescribe As A VMP
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
A11CC05
BNF Codes
  • BNF code 09050408
SNOMED Codes
Code Start Date End Date
4706111000001108 04-07-2003

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Calcium gluconate Based on Ingredient Substance 243 mg
Cobalt sulfate Based on Ingredient Substance 270 microgram
Colecalciferol Based on Ingredient Substance 1.25 microgram
Copper sulfate Based on Ingredient Substance 270 microgram
Disodium hydrogen phosphate dodecahydrate Based on Ingredient Substance 19 mg
Ferrous gluconate Based on Ingredient Substance 540 microgram
Magnesium phosphate Based on Ingredient Substance 4 mg
Manganese sulfate Based on Ingredient Substance 540 microgram
Potassium citrate Based on Ingredient Substance 132 mg
Potassium iodide Based on Ingredient Substance 3 microgram
Zinc sulfate Based on Ingredient Substance 270 microgram

Parent Products

  • VTM
    No Parent VTM
    • VMP
      (Current) Generic Minalka tablets
      • AMP

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
120 tablet
360 tablet